Morepen Laboratories Ltd (MOREPENLAB)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Morepen Laboratories Ltd (MOREPENLAB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011856
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Morepen Laboratories Ltd (Morepen Laboratories) is a manufacturer of active pharma ingredients and formulations. The company offers active pharma ingredients, formulation and homehealth solutions. It offers products in various formulations which include tablets, capsules, liquids and powders. Morepen Laboratories’ products categories comprise intermediate, drug master files and branded prescription drugs. The company’s homehealth segment offers various products such as blood glucose monitors, blood pressure monitors, nebulizers, weighing scales, vaporizers, pulse oximeters, adult diapers and quickchek pregnancy tests, among others. It operates in India and the US. Morepen Laboratories is headquartered in New Delhi, India.

Morepen Laboratories Ltd (MOREPENLAB) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Morepen Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Morepen Laboratories Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Morepen Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Morepen Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Morepen Laboratories Ltd, Medical Devices Deals, 2011 to YTD 2017 10
Morepen Laboratories Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Morepen Laboratories Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Morepen Lab Enters into Agreement with Vesale Pharma 12
Asset Transactions 13
Piramal Enterprises Plans to Acquire Over The Counter Business from Morepen Labs 13
Acquisition 14
Pinfold Overseas Acquires Additional 6.4% Stake in Morepen Labs 14
Morepen Laboratories Ltd – Key Competitors 15
Morepen Laboratories Ltd – Key Employees 16
Morepen Laboratories Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Feb 08, 2017: Morepen labs reports yet another growth-filled quarter 18
Nov 09, 2016: Morepen Labs reports 118 pct jump in net profits for the Q2 of FY 2016-17 20
Corporate Communications 21
Nov 10, 2016: Morepen Labs: Appoints Additional Director 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Morepen Laboratories Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Morepen Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Morepen Laboratories Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Morepen Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Morepen Laboratories Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Morepen Laboratories Ltd, Medical Devices Deals, 2011 to YTD 2017 10
Morepen Laboratories Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Morepen Lab Enters into Agreement with Vesale Pharma 12
Piramal Enterprises Plans to Acquire Over The Counter Business from Morepen Labs 13
Pinfold Overseas Acquires Additional 6.4% Stake in Morepen Labs 14
Morepen Laboratories Ltd, Key Competitors 15
Morepen Laboratories Ltd, Key Employees 16
Morepen Laboratories Ltd, Other Locations 17
Morepen Laboratories Ltd, Subsidiaries 17

★海外企業調査レポート[Morepen Laboratories Ltd (MOREPENLAB)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sterling Energy plc (SEY)(石油・ガス分野):企業M&A動向
    Summary Sterling Energy Plc (Sterling) is an oil and gas company. The company acquires, explores, develops and produces oil and natural gas assets. Its projects include Ntem, Ambilobe, Ampasindava and Odewayne. Sterling’s Ntem is a located in the southern Douala and Rio Muni Basin; Ambilobe is situa …
  • Chromalloy Gas Turbine LLC:企業の戦略・SWOT・財務分析
    SummaryChromalloy Gas Turbine LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • G4S plc:企業の戦略・SWOT・財務情報
    G4S plc - Strategy, SWOT and Corporate Finance Report Summary G4S plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • The TJX Companies, Inc. (TJX):企業の財務・戦略的SWOT分析
    The TJX Companies, Inc. (TJX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Temple-Inland, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Temple-Inland, Inc. Mergers and …
  • Puma Biotechnology, Inc. (PBYI):企業概要、財務及び戦略的SWOT分析
    Summary Puma Biotechnology, Inc. (Puma) is a biopharmaceutical company. The company develops and markets novel therapeutics for the treatment of cancer. It focuses on in-licensing drug candidates undergoing initial clinical testing for the treatment of cancer and develops those drug candidates for c …
  • SMC Corporation (6273):企業の財務・戦略的SWOT分析
    SMC Corporation (6273) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Acurity Health Group Limited (ACY):企業概要、財務及び戦略的SWOT分析
    Summary Acurity Health Group Limited (Acurity Health) is a surgical healthcare service provider. The center offers services, such as medicine, surgery and patient care. Its services include surgical services, post-operative care and range of diagnostic and ancillary services. It operates through thr …
  • Agilent Technologies, Inc.:戦略・SWOT・企業財務分析
    Agilent Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Agilent Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Euro Disney S.C.A.:戦略・SWOT・企業財務分析
    Euro Disney S.C.A. - Strategy, SWOT and Corporate Finance Report Summary Euro Disney S.C.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Infogroup, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Infogroup, Inc. Mergers and Acq …
  • The Williams Companies, Inc.:企業の戦略・SWOT・財務分析
    SummaryThe Williams Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company …
  • Adaptimmune Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Adaptimmune Ltd (Adaptimmune) a subsidiary of Adaptimmune Therapeutics plc operates as a clinical trials and pipeline company. The company engaged in developing T-cell receptors for T-cell therapy and SPEAR TCR therapies. Its clinical trials include synovial sarcoma trial, multiple myeloma t …
  • Caltex Australia Limited (CTX):企業のM&A・提携動向(石油・ガス分野)
    Summary Caltex Australia Limited (Caltex) is a transport fuel supplier and convenience retailer. It is the parent company of Caltex group. The company carries out the purchase, refining, distribution and marketing of petroleum products. It owns and operates fuel refineries, convenience stores, road …
  • StoneMor Partners L.P.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' StoneMor Partners L.P. Mergers …
  • Tribridge, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Tribridge, Inc. Mergers and Acq …
  • CSG Holding Co., Ltd. (000012):企業概要、財務及び戦略的SWOT分析
    Summary CSG Holding Co., Ltd. (CSG Holding) is a glass manufacturer. The company operates through Flat Glass, Architectural Glass, Fine Glass and Solar Energy. Its products include flat glass, architectural glass, fine glass, structural ceramics, silicon material, solar energy glass and solar cell. …
  • American Capital, Ltd.:企業の戦略・SWOT・財務分析
    SummaryAmerican Capital, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • Top Glove Corporation Berhad (TOPGLOV):企業概要、財務及び戦略的SWOT分析
    Summary Top Glove Corporation Berhad (Top Glove) is a rubber gloves manufacturing company. It offers products such as latex gloves, nitrile gloves, vinyl gloves, surgical gloves, household gloves, cleanroom gloves, cast polyethylene (CPE) gloves, industrial or long length high risk gloves and thermo …
  • Alligator Bioscience AB:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Alligator Bioscience AB Mergers …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆